Icon

ABSTRAL (nda022510)- (EQ 0.1MG BASE,EQ 0.2MG BASE,EQ 0.3MG BASE,EQ 0.4MG BASE,EQ 0.6MG BASE,EQ 0.8MG BASE)

FENTANYL CITRATE SENTYNL THERAPS INC
EQ 0.1MG BASE,EQ 0.2MG BASE,EQ 0.3MG BASE,EQ 0.4MG BASE,EQ 0.6MG BASE,EQ 0.8MG BASE
Yes Yes
2019-Sep-24 Expired
None None
None No
ABSTRAL is an opioid analgesic indicated only for the management of breakthrough pain in cancer patients, 18 years of age and older, who are already receiving and who are tolerant to opioid therapy for their underlying persistent cancer pain.
0 0 0
Total Other Developers None
Drugs with Suitability No
EQ 0.1MG BASE ** ** - - -
EQ 0.2MG BASE ** ** - - -
EQ 0.3MG BASE ** ** - - -
EQ 0.4MG BASE ** ** - - -
EQ 0.6MG BASE ** ** - - -
EQ 0.8MG BASE ** ** - - -
NDA Sales Available Total Generic Sales Available
No 0
ANDA No Generic Co Manufacturer Name Operations Manufacturer Address Country

Download GenUS Drug Report


Download GenUS Detailed Report


To get detailed report Contact Us

GenUs Advanced Search




Expired
to
Expired
to


Brand Name Generic Name Strength Dosage Route of Administration Innovator ParaIV

Please contact contact@researchdelta.com to get more details.